🇪🇺 Evenity in European Union

Evenity (romosozumab) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/004465
  • Local brand name: Evenity
  • Status: approved

Evenity in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Bone approved in European Union

Frequently asked questions

Is Evenity approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Evenity in European Union?

Amgen is the originator. The local marketing authorisation holder may differ — check the official source linked above.